Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04163952
Title Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016 United States Details
New York University Langone Medical Center New York New York 10016 United States Details
NYU Langone Medical Center (Tisch Hospital) New York New York 10016 United States Details
Duke University Medical Center - Duke Cancer Center Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field